Export Market Development Grants (EMDG)
The Export Market Development Grants (EMDG) scheme is a key Australian Government financial assistance program for aspiring and current exporters. Administered by Austrade, the scheme supports a wide range of industries.
Simplifying the Export Market Development Grant (EMDG) scheme
The Minister for Trade, Tourism and Investment, Senator the Hon Simon Birmingham, has released the independent review of financial assistance to SME exporters and the Export Market Development Grants (EMDG) scheme undertaken by Ms Anna Fisher, co-owner of Zonte’s Footstep.
The Minister has accepted in principle all ten recommendations of the review. The Government will reorient the EMDG scheme to replace the current reimbursement scheme with a more targeted grants program which will provide funding certainty upfront for eligible exporters.
For more information, please visit Reform of the Export Market Development Grant scheme
Increase in funding
On 1 April 2020, the Federal Government announced an increase in funding for the Export Market Development Grants (EMDG) scheme. Funding for the scheme will increase by $49.8 million in the 2019-20 financial year, allowing exporters and tourism businesses to get additional reimbursements for costs incurred in marketing their products and services around the world.
This supplements the additional $60 million already committed by the Government, and brings EMDG funding to its highest level in more than 20 years at $207.7 million for the 2019-20 financial year.
Further COVID-19 response
In addition to increased EMDG program funding, the Minister for Trade, Tourism and Investment, Senator the Hon Simon Birmingham has waived the EMDG export performance requirements for 2020–21. This will ensure businesses will not have their EMDG reimbursement reduced should their export income fall due to COVID-19.
To further assist exporters in 2020–21, the Minister has determined the Initial Payment Ceiling Amount (IPCA) to be $100,000. This is the highest IPCA since the scheme’s budget was capped in 1997–98, and a significant increase from the $40,000 IPCA set for the past five years.